AFIB
Income statement / Annual
Last year (2023), Acutus Medical, Inc.'s total revenue was $7.16 M,
a decrease of 56.22% from the previous year.
In 2023, Acutus Medical, Inc.'s net income was -$81.66 M.
See Acutus Medical, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$7.16 M
|
$16.36 M
|
$17.26 M
|
$8.46 M
|
$2.84 M
|
$2.17 M
|
| Cost of Revenue |
$10.30 M |
$31.91 M |
$32.93 M |
$15.89 M |
$9.24 M |
$7.51 M |
| Gross Profit |
-$3.14 M |
-$15.55 M |
-$15.66 M |
-$7.43 M |
-$6.41 M |
-$5.34 M |
| Gross Profit Ratio |
-0.44 |
-0.95 |
-0.91 |
-0.88 |
-2.26 |
-2.47 |
| Research and Development
Expenses |
$3.48 M
|
$28.15 M
|
$36.68 M
|
$33.45 M
|
$38.03 M
|
$19.08 M
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$26.85 M
|
$13.33 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$26.85 M
|
$13.33 M
|
| Selling, General &
Administrative Expenses |
$7.74 M
|
$47.65 M
|
$63.52 M
|
$50.36 M
|
$26.85 M
|
$13.33 M
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$97,000.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$11.22 M |
$75.81 M |
$100.21 M |
$83.81 M |
$64.88 M |
$32.41 M |
| Cost And Expenses |
$21.53 M |
$107.72 M |
$133.13 M |
$99.70 M |
$74.12 M |
$39.92 M |
| Interest Income |
$2.59 M |
$868,000.00 |
$116,000.00 |
$436,000.00 |
$1.16 M |
$297,000.00 |
| Interest Expense |
$5.66 M |
$5.15 M |
$5.68 M |
$5.51 M |
$22.27 M |
$5.23 M |
| Depreciation &
Amortization |
$874,000.00
|
$1.21 M
|
$6.89 M
|
$3.90 M
|
$3.17 M
|
$2.12 M
|
| EBITDA |
-$13.49 M
|
$35.21 M
|
-$105.12 M
|
-$91.33 M
|
-$68.12 M
|
-$40.56 M
|
| EBITDA Ratio |
-1.88 |
-5.09 |
-6.31 |
-10.27 |
-23.61 |
-16.74 |
| Operating Income Ratio
|
-2
|
-1.67
|
-6.49
|
-10.79
|
-25.59
|
-17.43
|
| Total Other
Income/Expenses Net |
$2.50 M
|
-$12.20 M
|
-$5.56 M
|
-$10.63 M
|
-$24.47 M
|
-$10.16 M
|
| Income Before Tax |
-$11.86 M |
-$39.53 M |
-$117.68 M |
-$101.96 M |
-$97.04 M |
-$47.91 M |
| Income Before Tax Ratio
|
-1.66
|
-2.42
|
-6.82
|
-12.05
|
-34.22
|
-22.12
|
| Income Tax Expense |
$63,000.00 |
$82,000.00 |
$5.68 M |
$23,000.00 |
$22.27 M |
-$4.93 M |
| Net Income |
-$81.66 M |
-$39.62 M |
-$123.36 M |
-$101.98 M |
-$119.31 M |
-$47.91 M |
| Net Income Ratio |
-11.4 |
-2.42 |
-7.15 |
-12.05 |
-42.07 |
-22.12 |
| EPS |
-2.81 |
-1.39 |
-4.31 |
-8.94 |
-4.35 |
-2.84 |
| EPS Diluted |
-2.81 |
-1.39 |
-4.31 |
-8.94 |
-4.35 |
-2.84 |
| Weighted Average Shares
Out |
$29.10 M
|
$28.47 M
|
$28.65 M
|
$11.41 M
|
$27.43 M
|
$16.85 M
|
| Weighted Average Shares
Out Diluted |
$29.10 M
|
$28.47 M
|
$28.65 M
|
$11.41 M
|
$27.43 M
|
$16.85 M
|
| Link |
|
|
|
|
|
|
